The American Journal of Medicine
Volume 113, Issue 3 , Pages 220-228 , 15 August 2002

Diagnosis and management of vertebral fractures in elderly adults

  • Alexandra Papaioannou, MD

      Affiliations

    • Department of Medicine, Division of Geriatric Medicine (AP) McMaster University, Hamilton, Ontario, Canada
    • Corresponding Author InformationRequests for reprints should be addressed to Alexandra Papaioannou, MD, Hamilton Health Sciences – Chedoke Site, Wilcox Building, Box 2000, Station A, Chedoke Campus, Sanatorium Road, Hamilton, Ontario L8N 3Z5, Canada
    • ,
  • Nelson B Watts, MD

      Affiliations

    • Department of Medicine (NBW), University of Cincinnati, Cincinnati, Ohio, USA
    • ,
  • David L Kendler, MD

      Affiliations

    • Department of Medicine (DLK), Division of Endocrinology, University of British Columbia, Vancouver, British Columbia, Canada
    • ,
  • Chui Kin Yuen, MD

      Affiliations

    • Department of Obstetrics (CKY), Gynecology and Reproductive Sciences, Department of Continuing Medical Education, University of Manitoba, Winnipeg, Manitoba, Canada
    • ,
  • Jonathan D Adachi, MD

      Affiliations

    • Division of Rheumatology (JDA), McMaster University, Hamilton, Ontario, Canada
    • ,
  • Nicole Ferko

      Affiliations

    • Department of Clinical Health Sciences (NF), McMaster University, Hamilton, Ontario, Canada

Received 4 January 2002 ,Revised 8 April 2002 ,Accepted 22 April 2002.

References 

  1. Genant HK, Cooper C, Poor G, et al.  Interim report and recommendations of the World Health Organization task-force for osteoporosis. Osteoporos Int. 1999;10:259–264
  2. Osteoporosis (review of the evidence for the prevention, diagnosis and treatment and cost-effectiveness analyses). Osteoporos Int. 1998;8(suppl 4):S1–S80
  3. Melton LJ, Chrischilles EA, Cooper C, et al.  How many women have osteoporosis?. J Bone Miner Res. 1992;7:1005–1010
  4. Nevitt MC, Ettinger B, Black DM, et al.  The association of radiographically detected vertebral fractures with back pain and function (a prospective study). Ann Intern Med. 1998;128:793–800
  5. Melton LJ, Lane A, Cooper C, et al.  Prevalence and incidence of vertebral deformities. Osteoporos Int. 1993;3:113–119
  6. Cummings SR, Black DM, Rubin SM. Lifetime risks of hip, Colle’s or vertebral fracture and coronary heart disease among white postmenopausal women. Arch Intern Med. 1989;149:2445–2448
  7. Reginster J, Minne HW, Sorensen OH, et al.  Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int. 2000;11:83–91
  8. Black DM, Thompson DE, Bauer DC, et al.  Fracture risk reduction with alendronate in women with osteoporosis (the fracture intervention trial. FIT Research Group). J Clin Endocrinol Metab. 2000;85:4118–4124
  9. Harris ST, Watts NB, Genant HK, et al.  Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis (a randomized controlled trial). JAMA. 1999;282:1344–1352
  10. Ettinger B, Black DM, Mitlak BH, et al.  Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene (results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators). JAMA. 1999;282:637–645
  11. Cooper C, Melton LJ. Vertebral fractures, how large is the silent epidemic?. BMJ. 1992;304:793–794
  12. Ross PD. Clinical consequences of vertebral fractures. Am J Med. 1997;102(suppl 6A):30S–43S
  13. Cooper C, Atkinson EJ, O’Fallon WM, Melton LJ. Incidence of clinically diagnosed vertebral fractures (a population-based study in Rochester, Minnesota, 1985–1989). J Bone Miner Res. 1992;7:221–227
  14. Melton LJ, Kan SH, Frye MA, et al.  Epidemiology of vertebral fractures in women. Am J Epidemiol. 1989;129:1000–1011
  15. O’Neill TW, Felsenberg D, Varlow J, et al.  The prevalence of vertebral deformity in European men and women (the European Vertebral Osteoporosis Study). J Bone Miner Res. 1996;11:1010–1018
  16. Jackson SA, Tenenhouse A, Robertson L. Vertebral fracture definition from population-based data (preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos)). Osteoporos Int. 2000;11:680–687
  17. Genant HK, Jergas M, Palermo L, et al.  Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1996;11:984–996
  18. Bauer RL, Deyo RA. Low risk of vertebral fracture in Mexican American women. Arch Intern Med. 1987;147:1437–1439
  19. Jacobsen SJ, Cooper C, Gottlieb MS, et al.  Hospitalization with vertebral fracture among the aged (a national population-based study). Epidemiology. 1992;3:515–518
  20. Aloia JF, Vaswani A, Yeh JK, Flaster E. Risk for osteoporosis in black women. Calcif Tissue Int. 1996;59:415–423
  21. Bohannon AD. Osteoporosis and African American women. J Womens Health Gend Based Med. 1999;8:609–615
  22. Ross PD, Davis JW, Epstein RS, Wasnich RD. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med. 1991;114:919–923
  23. Ross PD, Fujiwara S, Huang C, et al.  Vertebral fracture prevalence in women in Hiroshima compared to Caucasians or Japanese in the US. Int J Epidemiol. 1995;24:1171–1177
  24. Greendale GA, Barrett-Connor E, Ingles S, Haile R. Late physical and functional effects of osteoporotic fractures in women (the Rancho Bernardo study). J Am Geriatr Soc. 1995;43:955–961
  25. Greendale GA, DeAmicis TA, Bucur A, et al.  A prospective study of the effect of fracture on measured physical performance (results from the MacArthur Study–MAC). J Am Geriatr Soc. 2000;48:546–549
  26. Cook DJ, Guyatt GH, Adachi JD, et al.  Quality of life issues in women with vertebral fractures due to osteoporosis. Arthritis Rheum. 1993;36:750–756
  27. Huang C, Ross PD. Vertebral fracture and other predictors of physical impairment and health care utilization. Arch Intern Med. 1996;156:2469–2475
  28. Rapado A. General management of vertebral fractures. Bone. 1996;18(suppl):191S–196S
  29. Schlaich C, Minne HW, Bruckner T, et al.  Reduced pulmonary function in patients with spinal osteoporotic fractures. Osteoporos Int. 1998;8:261–267
  30. Leech JA, Hodder RV, Ooi DS, Gay J. Effects of short term inhaled budesonide and beclomethasone diproprionate on serum osteocalcin in premenopausal women. Am J Rev Respir Dis. 1993;148:113–115
  31. Nevitt MC, Thompson DE, Black DM, et al.  Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Fracture Intervention Trial Research Group. Arch Intern Med. 2000;160:77–85
  32. Johnell O, Gullberg B, Kanis JA. The hospital burden of vertebral fracture in Europe (a study of National Register Sources). Osteoporos Int. 1997;7:138–144
  33. Jacobsen SJ, Cooper C, Gottlieb MS, et al.  Hospitalization with vertebral fracture among the aged. Epidemiology. 1992;3:515–518
  34. Riggs BL, Melton LJ. The worldwide problem of osteoporosis (insights afforded by epidemiology). Bone. 1995;17(suppl 5):505S–511S
  35. Papaioannou A, Adachi JD, Parkinson W, et al.  Lengthy hospitalization associated with vertebral fractures despite control for co-morbid conditions. Osteoporos Int. 2001;12:870–874
  36. Klotzbeucher CM, Ross PD, Landsman PB, et al.  Patients with prior fracture have an increased risk of future fracture (summary of the literature and statistical synthesis). J Bone Miner Res. 2000;15:721–727
  37. Black DM, Arden NK, Palermo L, et al.  Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1999;14:821–828
  38. Lindsay R, Silverman SL, Cooper C, et al.  Risk of new vertebral fracture in the year following a fracture. JAMA. 2001;285:320–323
  39. Kado DM, Browner WS, Palermo L, et al.  Vertebral fractures and mortality in older women (a prospective study. Study of Osteoporotic Fractures Research Group). Arch Intern Med. 1999;159:1215–1220
  40. Ensrud KE, Thompson DE, Cauley JA, et al.  Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. J Am Geriatr Soc. 2000;48:241–249
  41. Cauley JA, Thompson DE, Ensrud KC, et al.  Risk of mortality following clinical fractures. Osteoporos Int. 2000;11:556–561
  42. Cooper C, Atkinson EJ, Jacobsen SJ, et al.  Population-based study of survival after osteoporotic fractures. Am J Epidemiol. 1993;137:1001–1005
  43. Ismail AA, O’Neill TW, Cooper C, et al.  Mortality associated with vertebral deformity with men and women (results from the European Prospective Osteoporosis Study (EPOS)). Osteoporos Int. 1998;8:291–297
  44. Center JR, Nguyen TV, Schneider D, et al.  Mortality after all major types of osteoporotic fracture in men and women (an observational study). Lancet. 1999;353:878–882
  45. Melton LJ. Excess mortality following vertebral fracture. J Am Geriatr Soc. 2000;48:338–339
  46. Von der Recke P, Hansen MA, Hassager C. The association between low bone mass at the menopause and cardiovascular mortality. Am J Med. 1999;106:273–278
  47. Vogt TM, Ross PD, Palermo L, et al.  Vertebral fracture prevalence among women screened for the fracture intervention trial and a simple clinical tool to screen for undiagnosed vertebral fractures. Mayo Clin Proc. 2000;75:888–896
  48. Ensrud KE, Black DM, Harris F, et al.  Correlates of kyphosis in older women. J Am Geriatr Soc. 1997;45:688–694
  49. Coles RJ, Clements DG, Evans WD. Measurement of height (practical considerations for the study of osteoporosis). Osteoporos Int. 1994;4:353–356
  50. Eastell R. Practical management of the patient with osteoporotic vertebral fracture. In:  Meunier PJ editors. Osteoporosis. Diagnosis and Management. London: Martin Dunitz Ltd; 1998;p. 175–190
  51. Kanis JA, Delmas P, Burckhardt P, et al.  Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease. Osteoporos Int. 1997;7:390–406
  52. Osteoporosis Society of Canada . Consensus Conference Statements. Prevention and management of osteoporosis (consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada). CMAJ. 1996;155(suppl):S921–S965
  53. Consensus Statement . Osteoporosis Prevention, Diagnosis and Therapy. March 27–29, 2000 2000; Vol 17. Bethesda, MD: National Institutes of Health Consensus Program
  54. Gelbach SH, Bigelow C, Heimisdottir M, et al.  Recognition of vertebral fracture in a clinical setting. Osteoporos Int. 2000;11:577–582
  55. Watts NB, Harris ST, Genant HK. Treatment of painful osteoporotic vertebral fracture with percutaneous vertebroplasty or kyphoplasty. Osteoporos Int. 2001;12:429–437
  56. Faulkner KG. Bone densitometry (choosing the proper skeletal site to measure). J Clin Densitom. 1998;1:279–285
  57. Chandler JM, Zimmerman SI, Girman CJ, et al.  Low bone mineral density and risk of fractures in white female nursing home residents. JAMA. 2000;284:972–977
  58. Greenspan SL, Cheng S, Miller PD, Orwoll ES. Clinical performance of a highly portable, scanning calcaneal ultrasonometer. Osteoporos Int. 2001;12:391–398
  59. Tamayo-Orozco J, Arzac-Palumbo P, Peon-Vidales H, et al.  Vertebral fractures associated with osteoporosis (patient management). Am J Med. 1997;103(suppl):44S–50S
  60. Gadsby JG, Flowerdew MW. Transcutaneous electrical nerve stimulation and acupuncture-like transcutaneous electrical nerve stimulation for chronic low back pain. Cochrane Database Syst Rev. 2000;2:CD000210
  61. Ghoname EA, Craig WF, White PF, et al.  Percutaneous electrical nerve stimulation for low back pain (a randomized cross-over study). JAMA. 1999;281:818–823
  62. Hernandez-Reif M, Field T, Krasnegor J, Theakston H. Lower back pain is reduced and range of motion increased after massage therapy. Int J Neurosci. 2001;106:131–145
  63. Ernst E. Complementary and alternative medicine in rheumatology. Baillieres Best Pract Res Clin Rheumatol. 2000;14:731–739
  64. Jellema P, van Tulder MW, Van Poppel MN, et al.  Lumbar supports for prevention and treatment of low back pain (a systematic review within the framework of the Cochrane Review Group). Spine. 2001;26:377–386
  65. Wolff I, van Croonenborg J, Kemper HCG, et al.  The effect of exercise training programs on bone mass (a meta-analysis of published controlled trials in pre- and postmenopausal women). Osteoporos Int. 1999;9:1–12
  66. Malmros B, Mortensen L, Jensen MB, Charles P. Positive effect of physiotherapy on chronic pain and performance in osteoporosis. Osteoporos Int. 1998;8:215–221
  67. Cummings SR, Nevitt MC, Browner WS, et al.  Risk factors for hip fracture in white women (Study of Osteoporotic Fractures Research Group). N Engl J Med. 1995;332:767–773
  68. Gillespie LD, Gillespie WJ, Robertson MC, et al.  Interventions for preventing falls in elderly people. Cochrane Database Syst Rev. 2001;3:CD000340
  69. Wolf SL, Barnhart HX, Kutner NG, et al.  Reducing frailty and falls in older persons (an investigation of Tai Chi and computerized balance training). J Am Geriatr Soc. 1996;44:489–497
  70. Brown FL, Bodison S, Dixon J, et al.  Comparison of diflunisal and acetaminophen with codeine in the treatment of initial or recurrent acute low back strain. Clin Ther. 1986;9(suppl C):52–58
  71. Innes GD, Croskerry P, Worthington J, et al.  Ketorolac versus acetaminophen-codeine in the emergency department treatment of acute low back pain. J Emerg Med. 1998;16:549–556
  72. Van Tulder MW, Scholten RJ, Koes BW, Deyo RA. Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev. 2000;2:CD000396
  73. Lyritis GP, Ioannidis GV, Karachalios T, et al.  Analgesic effect of salmon calcitonin suppositories in patients with acute pain due to recent osteoporotic vertebral crush fractures (a prospective double-blind, randomized, placebo-controlled clinical study). Clin J Pain. 1999;15:284–289
  74. Ljunhall S. Synthetic human calcitonin in postmenopausal osteoporosis (a placebo-controlled double-blind study). Calcif Tissue Int. 1991;49:17–19
  75. Pun KK. Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic fractures. Clin Ther. 1989;11:205–209
  76. Lyritis GP, Paspati I, Karachalios T, et al.  Pain relief from nasal salmon calcitonin in osteoporotic vertebral crush fractures. A double blind, placebo-controlled clinical study. Acta Orthop Scan Suppl. 1997;275:112–114
  77. Maksymowych WP. Managing acute osteoporotic vertebral fractures with calcitonin. Can Fam Physician. 1998;44:2160–2166
  78. Chandler G, Dalley G, Hemmer J, Seely T. Gray ramus communication nerve block (novel treatment for painful osteoporotic vertebral compression fractures). South Med J. 2001;94:387–393
  79. Levine SA, Perin LA, Hayes D, et al.  An evidence-based evaluation of percutaneous vertebroplasty. Manag Care. 2000;9:56–63
  80. Cortet B, Cotten A, Boutry N, et al.  Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures (an open prospective study). J Rheumatol. 1999;26:2222–2228
  81. Liu BA, Gordon M, Labranche JM, et al.  Seasonal prevalence of vitamin D deficiency in institutionalized older adults. J Am Geriatr Soc. 1997;45:598–603
  82. McKenna MJ. Differences in vitamin D status between countries in young adults and the elderly. Am J Med. 1992;93:69–77
  83. Looker AC, Gunter EW. Hypovitaminosis D in medical inpatients. [letter] N Engl J Med. 1998;339:344–345
  84. Gillespie WJ, Henry DA, O’Connell DL, Robertson J. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev. 2001;1:CD000227
  85. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of withdrawal of calcium and vitamin D supplements on bone mass in elderly men and women. Am J Clin Nutr. 2000;72:745–750
  86. Chapuy MC, Arlot ME, Duboef F, et al.  Vitamin D3 and calcium prevent hip fractures in elderly women. N Engl J Med. 1992;327:1637–1642
  87. Chestnut CH, Silverman S, Andriano K, et al.  A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis (the Prevent Recurrence of Osteoporotic Fractures Study). Am J Med. 2000;109:267–276
  88. Harris ST, Watts NB, Jackson RD, et al.  Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis (three years of blinded therapy followed by one year of open therapy). Am J Med. 1993;95:557–567
  89. Neer RM, Arnaud CD, Zanchetta JR, et al.  Effect of parathyroid hormone on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344:1434–1441
  90. Orwoll E, Ettinger M, Weiss S, et al.  Alendronate for the treatment of osteoporosis in men. N Engl J Med. 2000;343:604–610
  91. Barett-Connor E, Grady D, Sashegyi A, et al.  Raloxifene and cardiovascular events in osteoporotic postmenopausal women. JAMA. 2002;287:847–856
  92. Torgerson DJ, Bell-Syer SE. Hormone replacement therapy and prevention of nonvertebral fractures. A meta-analysis of randomized trials. JAMA. 2001;285:2891–2897
  93. Villareal DT, Binder EF, Williams DB, et al.  Bone mineral density response to estrogen replacement in frail elderly women. JAMA. 2001;286:815–820
  94. Torgerson DJ, Bell-Syer SE. Hormone replacement therapy and prevention of vertebral fractures (a meta-analysis of randomised trials). BMC Musculoskelet Disord. 2001;2:7

PII: S0002-9343(02)01190-7

The American Journal of Medicine
Volume 113, Issue 3 , Pages 220-228 , 15 August 2002

Article Tools